Federal Court OKs Celera's $23M Settlement with Former Shareholders | GenomeWeb

NEW YORK (GenomeWeb) – A federal court this week preliminarily approved an agreement in which Celera will pay former shareholders $23 million to settle a five-year-old lawsuit that alleged the company made materially false and misleading financial statements, inflating its stock price. 

As part of the decision handed down on Tuesday by the US District Court for the Northern District of California, co-defendant PriceWaterhouseCoopers has also agreed to pay $1.75 million to settle the litigation. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.